Gene: TMEM176A
Official Full Name: transmembrane protein 176Aprovided by HGNC
Gene Summary: Predicted to act upstream of or within negative regulation of dendritic cell differentiation. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00269 | TMEM176A Knockout cell line (HeLa) | Human | TMEM176A | 1:3~1:6 | Negative | Online Inquiry |
TMEM176A Gene Knockout Cell Lines are advanced genetically engineered cell lines specifically designed to study the function of the TMEM176A gene, which is implicated in various biological processes, including immune response and cellular metabolism. This product provides researchers with a powerful tool for investigating the role of TMEM176A in both normal physiology and disease states.
The key mechanism behind these knockout cell lines involves the targeted deletion of the TMEM176A gene, achieved through CRISPR/Cas9 technology. This precise genome editing allows for the elucidation of the gene's contributions to cellular pathways, enabling a deeper understanding of its functional significance. Researchers can use these knockout cells to assess changes in cellular behavior, gene expression profiles, and signaling pathways, making them invaluable for investigating diseases like cancer and autoimmune disorders.
In the realm of scientific research, TMEM176A Gene Knockout Cell Lines hold substantial importance. They serve as critical models for preclinical studies and drug discovery, facilitating the identification of potential therapeutic targets. Their applications extend to academia and the pharmaceutical industry, where they contribute to the development of novel treatment strategies.
Compared to traditional methods of gene inhibition, such as shRNA or siRNA, these knockout cell lines provide a robust, permanent modification of the target gene, offering more reliable experimental outcomes. This permanence ensures that researchers can conduct repetitive experiments without variability introduced by transient knockdown methods.
For researchers, clinicians, and pharmaceutical developers, TMEM176A Gene Knockout Cell Lines are a valuable asset, enabling rigorous investigation and fostering innovation in genetic research. By utilizing this product, users can harness the power of genetic knockout technology to drive forward their studies and clinical advancements.
Our company specializes in the development of high-quality biological products, leveraging cutting-edge techniques and an in-depth understanding of genetic engineering to provide solutions that meet the evolving needs of researchers and clinicians in the field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.